Insider · CIK 0001242882
Mitchell Gold
Files at ALPN (ALPINE IMMUNE SCIENCES, INC.), ATTO (Attovia Therapeutics, Inc.). First filing Dec 12, 2023, latest Dec 29, 2023.
In brief
Mitchell Gold files SEC Form 4 as director, CEO and chair at ALPN (ALPINE IMMUNE SCIENCES, INC.), and also at ATTO (Attovia Therapeutics, Inc.). Since Dec 12, 2023, Mitchell Gold has reported 0 open-market buys worth $0 and 4 open-market sells worth $4.0M, the latest filed on Dec 29, 2023.
A track record needs three past buys with six months of prices behind them; Mitchell Gold has 0, so none is measured yet.
The newest scored trade: sold $20k of ALPN on Dec 28, 2023, filed Dec 29, 2023, scored 25 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | ALPINE IMMUNE SCIENCES, INC. | $20k 1,016 shares | -100% | - | |
| 50Moderate | ALPINE IMMUNE SCIENCES, INC. | $1.9M 91,884 shares | -243% | - | |
| 32Weak | ALPINE IMMUNE SCIENCES, INC. | $48k 2,402 shares | -100% | - | |
| 43Moderate | ALPINE IMMUNE SCIENCES, INC. | $2.0M 118,000 shares | -108% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 19, 2023 | Alpine Immune Sciences, Inc. | 120,000 0.21% of outstanding | $2.4M | Dec 19, 2023 | $2.0M |
| Dec 8, 2023 | Alpine Immune Sciences, Inc. | 118,000 0.20% of outstanding | $2.0M | Dec 8, 2023 | none |
Transactions
Every row this insider has filed, 43 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | ATTO Attovia Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Aug 6, 2026 |
| May 18, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | UTender of shares Common Stockindirect: Alpine ImmunoSciences, L.P. | -2,627,157 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -13,245 | - | - | 96,000 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -96,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -70,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -247,951 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -208,916 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -200,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -270,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -255,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -215,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -336,755 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -240,000 | - | - | 0 | May 20, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +13,245 | $7.55 | $100k | 109,245 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -13,245 | $0.00 | $0 | 336,755 | May 10, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Common Stock | +96,000 | $0.00 | $0 | 96,000 | Jan 5, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Stock Option (Right to buy)derivative | +240,000 | $0.00 | $0 | 240,000 | Jan 5, 2024 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +1,016 | $0.65 | $660 | 1,016 | Dec 29, 2023 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -1,016 | $20.04 | $20k | 0 | Dec 29, 2023 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stockindirect: Alpine ImmunoSciences, L.P.10b5-1 | +74,441 | $12.74 | $948k | 2,675,421 | Dec 29, 2023 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | FTax withholding Common Stockindirect: Alpine ImmunoSciences, L.P.10b5-1 | -48,264 | $19.65 | $948k | 2,627,157 | Dec 29, 2023 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -1,016 | $0.00 | $0 | 247,951 | Dec 29, 2023 |
| Dec 28, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Warrant (right to buy)derivativeindirect: Alpine ImmunoSciences, L.P.10b5-1 | -74,441 | $0.00 | $0 | 0 | Dec 29, 2023 |
| Dec 22, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +37,825 | $0.45 | $17k | 37,825 | Dec 27, 2023 |
| Dec 22, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -37,825 | $20.43 | $773k | 0 | Dec 27, 2023 |
| Dec 26, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +2,402 | $0.45 | $1,081 | 2,402 | Dec 27, 2023 |
| Dec 26, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +22,084 | $0.65 | $14k | 24,486 | Dec 27, 2023 |
| Dec 26, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -24,486 | $20.22 | $495k | 0 | Dec 27, 2023 |
| Dec 27, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +29,573 | $0.65 | $19k | 29,573 | Dec 27, 2023 |
| Dec 27, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -29,573 | $20.04 | $593k | 0 | Dec 27, 2023 |
| Dec 22, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -37,825 | $0.00 | $0 | 2,402 | Dec 27, 2023 |
| Dec 26, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -2,402 | $0.00 | $0 | 0 | Dec 27, 2023 |
| Dec 26, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -22,084 | $0.00 | $0 | 278,540 | Dec 27, 2023 |
| Dec 27, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -29,573 | $0.00 | $0 | 248,967 | Dec 27, 2023 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +2,402 | $0.45 | $1,081 | 2,402 | Dec 21, 2023 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -2,402 | $20.01 | $48k | 0 | Dec 21, 2023 |
| Dec 19, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -2,402 | $0.00 | $0 | 40,227 | Dec 21, 2023 |
| Dec 8, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -8,067 | $17.08 | $138k | 101,320 | Dec 12, 2023 |
| Dec 11, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -68,870 | $17.26 | $1.2M | 32,450 | Dec 12, 2023 |
| Dec 12, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -32,450 | $17.32 | $562k | 0 | Dec 12, 2023 |
| Dec 12, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock10b5-1 | +8,613 | $0.45 | $3,876 | 8,613 | Dec 12, 2023 |
| Dec 12, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -8,613 | $17.32 | $149k | 0 | Dec 12, 2023 |
| Dec 12, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative10b5-1 | -8,613 | $0.00 | $0 | 42,629 | Dec 12, 2023 |
Questions about Mitchell Gold
Answered from the filings on this page, as of the latest one.
Is Mitchell Gold buying or selling?
Not in the last 12 months. Mitchell Gold's latest open-market trade on SEC Form 4 was sold $20k of ALPN on Dec 28, 2023.
How did Mitchell Gold's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mitchell Gold has 0.
Where does Mitchell Gold file Form 4?
Mitchell Gold has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.) as Executive Chairman and CEO; ATTO (Attovia Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.